Prefer a chat interface with context about you and your work?
Bayesian sample size determination in non‐sequential clinical trials: Statistical aspects and some regulatory considerations
Abstract The most common Bayesian methods for sample size determination (SSD) are reviewed in the non‐sequential context of a confirmatory phase III trial in drug development. After recalling the regulatory viewpoint on SSD, we discuss the relevance of the various priors applied to the planning of clinical trials. We then …